Related references
Note: Only part of the references are listed.Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation
Paul R. Territo et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis
Wissam Beaino et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response
Junbin Han et al.
NUCLEAR MEDICINE COMMUNICATIONS (2017)
The Microglial ATP-Gated Ion Channel P2X7 As a CNS Drug Target
Anindya Bhattacharya et al.
GLIA (2016)
Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates
Dieter Ory et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Purinergic mechanisms in neuroinflammation: An update from molecules to behavior
Edward Beamer et al.
NEUROPHARMACOLOGY (2016)
P2X ion channel receptors and inflammation
Geoffrey Burnstock
PURINERGIC SIGNALLING (2016)
Synthesis of [11C]GSK1482160 as a new PET agent for targeting P2X7 receptor
Mingzhang Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [11C]A-740003 as a novel tracer of neuroinflammation
Bieneke Janssen et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2014)
Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567
Anindya Bhattacharya et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists
Michael A. Letavic et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors
Caroline Vandeputte et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Discovery and Biological Evaluation of Novel Cyanoguanidine P2X7 Antagonists with Analgesic Activity in a Rat Model of Neuropathic Pain
Arturo Perez-Medrano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Prisca Honore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Hit-to-lead studies:: The discovery of potent adamantane amide P2X7 receptor antagonists
A Baxter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)